← 產業報告目錄
Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report, By Type (Innovative APIs Generic APIs), By Type of Drug (Prescription, Over the Counter), By Potency (Traditional APIs, High Potency APIs) By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-13頁數 180報告編號 INSIGHTACE-d5a260937b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 178.2 Billion as of 2024, the global Active Pharmaceutical Ingredients Market is forecasted to climb to USD 374.6 Billion by 2034, reflecting a compound annual growth rate of 7.8% over the 2025–2034 period.
Active Pharmaceutical Ingredients covers responsible for the growth. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Market momentum is supported by rising call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Active Pharmaceutical Ingredients Market Snapshot
Chapter 4. Global Active Pharmaceutical Ingredients Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. By Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Innovative APIs
5.2.2. Generic APIs
Chapter 6. Market Segmentation 2: By Synthesis Estimates & Trend Analysis
6.1. By Synthesis & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Synthesis:
6.2.1. Synthetic APIs
6.2.2. Innovative Synthetic APIs
6.2.2.1. Generic Synthetic APIs
6.2.3. Biotech APIs
6.2.3.1. By Type
6.2.3.1.1. Innovative Biotech APIs
6.2.3.1.2. Generic Biotech APIs
6.2.3.2. By Product
6.2.3.2.1. Monoclonal Antibodies
6.2.3.2.2. Hormones and Growth Factors
6.2.3.2.3. Fusion proteins
6.2.3.2.4. Cytokines
6.2.3.2.5. Therapeutic enzymes
6.2.3.2.6. Blood factors and Anti-coagulants
6.2.3.2.7. Recombinant vaccines
6.2.3.3. By Expression Systems
6.2.3.3.1. Mammalian expression systems
6.2.3.3.2. Microbial expression systems
6.2.3.3.3. Yeast expression systems
6.2.3.3.4. Insect expression systems
6.2.3.3.5. Other expression system
Chapter 7. Market Segmentation 3: By Type of Drug Estimates & Trend Analysis
7.1. By Type of Drug & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Drug:
7.2.1. Prescription
7.2.2. Over the Counter
Chapter 8. Market Segmentation 4: By Potency Estimates & Trend Analysis
8.1. By Potency & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Potency:
8.2.1. Traditional APIs
8.2.2. High Potency APIs
Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis
9.1. By End-User & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User:
9.2.1. Pharmaceutical & Biotechnology Industry
9.2.2. Contract Research Organization
9.2.3. Contract manufacturing Organization
9.2.4. Others
Chapter 10. Active Pharmaceutical Ingredients Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
10.1.2. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Synthesis, 2021-2034
10.1.3. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Type of Drug, 2021-2034
10.1.4. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By Potency, 2021-2034
10.1.5. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
10.1.6. North America Active Pharmaceutical Ingredients Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, 2021-2034
10.2.2. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, 2021-2034
10.2.3. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, 2021-2034
10.2.4. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, 2021-2034
10.2.5. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, 2021-2034
10.2.6. Europe Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, 2021-2034
10.3.2. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, 2021-2034
10.3.3. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, 2021-2034
10.3.4. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, 2021-2034
10.3.5. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, 2021-2034
10.3.6. Asia Pacific Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
10.4.2. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, (US$ Million) 2021-2034
10.4.3. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, (US$ Million) 2021-2034
10.4.4. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, (US$ Million) 2021-2034
10.4.5. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034
10.4.6. Latin America Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
10.5.2. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Synthesis, (US$ Million) 2021-2034
10.5.3. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Type of Drug, (US$ Million) 2021-2034
10.5.4. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By Potency, (US$ Million) 2021-2034
10.5.5. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034
10.5.6. Middle East & Africa Active Pharmaceutical Ingredients Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. UPL
11.2.2. Pfizer Inc.
11.2.3. Teva Pharmaceutical Industries Ltd.
11.2.4. GSK PLC
11.2.5. Sanofi
11.2.6. Viatris Inc.
11.2.7. Divi's Laboratories Limited
11.2.8. Sandoz Group AG
11.2.9. Boehringer Ingelheim International Gmbh
11.2.10. Sk Inc.
11.2.11. Eli Lilly And Company
11.2.12. Merck Kgaa
11.2.13. Abbvie Inc.
11.2.14. F. Hoffmann-La Roche Ltd.
11.2.15. Astrazeneca
11.2.16. Dr. Reddy's Laboratories Ltd.
11.2.17. Sun Pharmaceutical Industries Ltd.
11.2.18. Cipla
11.2.19. Evonik Industries Ag
11.2.20. Hikma Pharmaceuticals Plc
11.2.21. BASF SE
11.2.22. Alembic Pharmaceuticals Limited
11.2.23. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們